Apart from the BG effect it looks like a few momentum players are in play. With no real buyers stepping up it looks easy money for them. The big thing for me is RAC hasn’t let anyone down atm, every announcement is positive and on track. True the potential buyout has probably been put back 18 months+ but for valid $$$$$ reasons. The SP is controlled by the market not RAC. When this recovers and it will, remember biotechs can increase in value very very quickly and I’m firmly in the camp that believes it will
RAC Price at posting:
$1.72 Sentiment: Buy Disclosure: Held
